NU-0129

N/A

Report date: 2025/08/19 20:00:08
NME

Base Information

Drug NameNU-0129
Drug Alias NameNU-0129
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionApoptosis regulator Bcl-2 inhibitors
TargetsApoptosis regulator Bcl-2
Therapy Area/IndicationsGliosarcomaGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNorthwest University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNorthwestern University
Active IndicationsN/A
Inactive IndicationsGliosarcomaGlioblastoma

Other Information

ATC CodeN/A
Related LinksN/A